AS

Arumoy Sarkar

Active Director Director DIN 09349377
DIN 09349377 First appointment Oct 2021 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Oct 2021
Shareholding value Locked Premium profile

About Arumoy Sarkar

Arumoy Sarkar has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Theramis Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09349377
Primary Designation Director
First Appointment 06 Oct 2021
Oldest Company Age 4 yrs

Current companies

Company Designation Appointment Founded Status
Director 06 Oct 2021 2021 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Theramis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arumoy Sarkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arumoy Sarkar

Arumoy Sarkar has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Theramis Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Arumoy Sarkar is associated with 1 company as Director.

Arumoy Sarkar has expertise in General Business.

Arumoy Sarkar has 4 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available